Skip to content
Vuja De Sciences logo

Vuja De Sciences Alternatives & Competitors

9 companies similar to Vuja De Sciences — Vuja De is dedicated to developing cancer metastasis treatments that prevent can...

Companies similar to Vuja De Sciences

Acomhal Research, Inc. logo — alternative to Vuja De Sciences

Acomhal Research, Inc.

Providing novel and effective therapeutic approaches to prevent tumor recurrence and metas...

Galera Therapeutics, Inc. logo — alternative to Vuja De Sciences

Galera Therapeutics, Inc.

Transforming the science and treatment of cancer

Inspirna, Inc. logo — alternative to Vuja De Sciences

Inspirna, Inc.

Converting cancer to a manageable, chronic condition

Oncorena AB logo — alternative to Vuja De Sciences

Oncorena AB

Developing a first-in-class treatment for advanced renal cancer

Rival Readout

Competing with Vuja De Sciences? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Sopherion Therapeutics logo — alternative to Vuja De Sciences

Sopherion Therapeutics

Innovating metastatic breast cancer treatment through advanced nanotechnology solutions.

Lantern Pharma Inc. (Nasdaq: LTRN) logo — alternative to Vuja De Sciences

Lantern Pharma Inc. (Nasdaq: LTRN)

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Ambit logo — alternative to Vuja De Sciences

Ambit

Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kina...

Cleveland Biolabs logo — alternative to Vuja De Sciences
Developing New Drugs for AML and PDAC logo — alternative to Vuja De Sciences

Developing New Drugs for AML and PDAC

Just received $2.5M to advance our AML immunotherapeutic.

About Vuja De Sciences

Vuja De Sciences is a biotechnology startup that is focused on developing treatments for cancer metastasis, with the aim of preventing cancer progression and recurrence. The company's initial focus is on osteosarcoma, a rare bone cancer that predominantly affects adolescents, before expanding to other types of cancer....

Business keywords

Cancer Metastasis Treatments, Preventing Cancer Progression, Recurrence Prevention, Osteosarcoma Treatment, Comparative Oncology, Metastatic Preclinical Endpoints, Drug Repurposing, Novel Preclinical Drugs, Canine Clinical Trials, Maintenance Therapy, Adjuvant Therapy, Phenotypic Screening, Pediatric Cancer, Drug Screening

Frequently Asked Questions

Companies similar to Vuja De Sciences include Acomhal Research, Inc., Galera Therapeutics, Inc., Inspirna, Inc., Oncorena AB, Sopherion Therapeutics. They work in Biotechnology and Health Care.
Bounce Watch lists 9 companies that share Vuja De Sciences's industries and are closest to it in business tags, services, target customers, business model and size.
Vuja De Sciences is a biotechnology startup that is focused on developing treatments for cancer metastasis, with the aim of preventing cancer progression and recurrence. The company's initial focus is on osteosarcoma, a rare bone cancer that predominantly affects adolescents, before expanding to other types of cancer....

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Vuja De Sciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Vuja De Sciences on 3 Dec 2024. The 9 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout